1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cerebral Palsy Global Clinical Trials Review, H1, 2014

Cerebral Palsy Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, H1, 2014" provides data on the Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cerebral Palsy Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Cerebral Palsy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cerebral Palsy to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cerebral Palsy to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cerebral Palsy 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Cerebral Palsy Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Ipsen S.A. 34
Clinical Trial Overview of Ipsen S.A. 34
Merz Pharma GmbH and Co. KgaA 35
Clinical Trial Overview of Merz Pharma GmbH and Co. KgaA 35
Medtronic, Inc. 36
Clinical Trial Overview of Medtronic, Inc. 36
Acorda Therapeutics, Inc. 37
Clinical Trial Overview of Acorda Therapeutics, Inc. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Top Institutes / Government 40
Eunice Kennedy Shriver National Institute of Child Health and Human Development 40
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 40
The Sheba Medical Center 41
Clinical Trial Overview of The Sheba Medical Center 41
Shriners Hospitals for Children 42
Clinical Trial Overview of Shriners Hospitals for Children 42
VU University Medical Center 43
Clinical Trial Overview of VU University Medical Center 43
Bundang Cha Hospital 44
Clinical Trial Overview of Bundang Cha Hospital 44
National Institute of Neurological Disorders and Stroke 45
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 45
Chang Gung Memorial Foundation 46
Clinical Trial Overview of Chang Gung Memorial Foundation 46
Stanford University 47
Clinical Trial Overview of Stanford University 47
Hvidovre University Hospital 48
Clinical Trial Overview of Hvidovre University Hospital 48
Shaare Zedek Medical Center 49
Clinical Trial Overview of Shaare Zedek Medical Center 49
Five Key Clinical Profiles 50
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 78

List of Tables
Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cerebral Palsy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cerebral Palsy Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Cerebral Palsy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 33
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 34
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH and Co. KgaA, 2014* 35
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014* 36
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 37
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 39
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 40
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 41
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014* 42
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 43
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bundang Cha Hospital, 2014* 44
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 45
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 46
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 47
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2014* 48
Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2014* 49

List of Figures
Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Cerebral Palsy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.